{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:02:04Z","timestamp":1781197324931,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.fct.2022.113185","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:42:11Z","timestamp":1653651731000},"page":"113185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Firm evidence for the detoxification of senecionine-induced hepatotoxicity via N-glucuronidation in UGT1A4\u2013humanized transgenic mice"],"prefix":"10.1016","volume":"165","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Zhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2022.113185_bib1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.119.089557","article-title":"Acetaminophen-induced liver injury alters expression and activities of cytochrome P450 enzymes in an age-dependent manner in mouse liver","volume":"48","author":"Bao","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.fct.2022.113185_bib2","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1021\/acs.molpharmaceut.0c00559","article-title":"Characterization of differential tissue abundance of major non-CYP enzymes in human","volume":"17","author":"Basit","year":"2020","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.fct.2022.113185_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/dmd.106.012070","article-title":"Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice","volume":"35","author":"Buckley","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2022.113185_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.fct.2019.05.024","article-title":"Risk assessment of intake of pyrrolizidine alkaloids from herbal teas and medicines following realistic exposure scenarios","volume":"130","author":"Chen","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2020.01.021","article-title":"The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica","volume":"323","author":"Chen","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2022.113185_bib6","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2022.113185_bib7","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.2174\/0929867325666180226111311","article-title":"UDP-glucuronosyltransferases: structure, function and drug design studies","volume":"25","author":"Erica","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.fct.2022.113185_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DMR-120028426","article-title":"Pyrrolizidine alkaloids\u2013genotoxicity, metabolism enzymes, metabolic activation, and mechanisms","volume":"36","author":"Fu","year":"2004","journal-title":"Drug Metab. Rev."},{"issue":"11","key":"10.1016\/j.fct.2022.113185_bib9","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1007\/s00204-020-02853-9","article-title":"In vitro biotransformation of pyrrolizidine alkaloids in different species: Part II-identification and quantitative assessment of the metabolite profile of six structurally different pyrrolizidine alkaloids","volume":"94","author":"Geburek","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0090-9556(25)07355-6","article-title":"Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein","volume":"24","author":"Green","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2022.113185_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/dmd.109.030460","article-title":"Identification of the UDP-glucuronosyltransferase isozyme involved in senecionine glucuronidation in human liver microsomes","volume":"38","author":"He","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2022.113185_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/tx900328f","article-title":"Glucuronidation, a new metabolic pathway for pyrrolizidine alkaloids","volume":"23","author":"He","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.31723","article-title":"Mutational signature analysis reveals widespread contribution of pyrrolizidine alkaloid exposure to human liver cancer","volume":"74","author":"He","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2022.113185_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00204-019-02582-8","article-title":"The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice","volume":"94","author":"Hessel-Pras","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101117","article-title":"(-)-Epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury","volume":"22","author":"Huang","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.fct.2022.113185_bib16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bcp.2006.01.004","article-title":"Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4","volume":"71","author":"Kaku","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.fct.2022.113185_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.fct.2022.113185_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389200003339171","article-title":"UDP-Glucuronosyltransferases","volume":"1","author":"King","year":"2000","journal-title":"Curr. Drug Metabol."},{"issue":"11","key":"10.1016\/j.fct.2022.113185_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/tx0255370","article-title":"Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine","volume":"15","author":"Lin","year":"2002","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.fct.2022.113185_bib20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/tx0340302","article-title":"Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat","volume":"16","author":"Lin","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","article-title":"Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum","volume":"54","author":"Lin","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2022.113185_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jfda.2018.05.005","article-title":"Pyrrole-protein adducts-a biomarker of pyrrolizidine alkaloid-induced hepatotoxicity","volume":"26","author":"Ma","year":"2018","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.fct.2022.113185_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0163-7258(91)90065-T","article-title":"Drug glucuronidation in human","volume":"51","author":"Miners","year":"1991","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.fct.2022.113185_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/carcin\/12.3.515","article-title":"Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver","volume":"12","author":"Miranda","year":"1991","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.fct.2022.113185_bib25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2012.07.004","article-title":"Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9","volume":"57","author":"Nakamura","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2022.113185_bib26","first-page":"825","article-title":"Hepatotoxicity of pyrrolizidine alkaloids","volume":"18","author":"Neuman","year":"2015","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.fct.2022.113185_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.fct.2022.113185_bib28","first-page":"404","article-title":"Blood pyrrole-protein adducts-a biomarker of pyrrolizidine alkaloid-induced liver injury in humans","volume":"33","author":"Ruan","year":"2015","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.fct.2022.113185_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.111107","article-title":"Pyrrolizidine alkaloids in food and phytomedicine: occurrence, exposure, toxicity, mechanisms, and risk assessment - a Review","volume":"136","author":"Schrenk","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.fct.2022.113185_bib31","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1124\/dmd.108.021469","article-title":"Species differences in UDP-glucuronosyltransferase activities in mice and rats","volume":"36","author":"Shiratani","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2022.113185_bib32","series-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","year":"2005"},{"issue":"1","key":"10.1016\/j.fct.2022.113185_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00216-011-5075-3","article-title":"The comparative pharmacokinetics of two pyrrolizidine alkaloids, senecionine and adonifoline, and their main metabolites in rats after intravenous and oral administration by UPLC\/ESIMS","volume":"401","author":"Wang","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"issue":"23","key":"10.1016\/j.fct.2022.113185_bib34","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.1097\/MD.0000000000000942","article-title":"Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.fct.2022.113185_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/a-1582-9794","article-title":"The role of kinetics as key determinant in toxicity of pyrrolizidine alkaloids and their N-oxides","volume":"88","author":"Widjaja","year":"2022","journal-title":"Planta Med."},{"key":"10.1016\/j.fct.2022.113185_bib36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(01)00020-4","article-title":"Senecio disease, or cirrhosis of the liver due to Senecio poisoning","volume":"196","author":"Willmot","year":"1920","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2022.113185_bib37","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s11306-011-0354-8","article-title":"UPLC-MS based metabolomics study on Senecio scandens and S. vulgaris: an approach for the differentiation of two Senecio herbs with similar morphology but different toxicity","volume":"8","author":"Xiong","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.fct.2022.113185_bib38","first-page":"54","article-title":"Identification of metabolites of senecionine, a hepatotoxic pyrrolizidine alkaloid, by liquid chromatography tandem mass spectrometry","volume":"47","author":"Xiong","year":"2012","journal-title":"Chin. Pharmaceut. J."},{"key":"10.1016\/j.fct.2022.113185_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/tx400451q","article-title":"Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid","volume":"27","author":"Xiong","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phymed.2018.06.015","article-title":"Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice","volume":"54","author":"Xiong","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.fct.2022.113185_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.toxicon.2020.07.015","article-title":"Protein cross-linking in primary cultured mouse hepatocytes by dehydropyrrolizidine alkaloids: structure-toxicity relationship","volume":"186","author":"Xiong","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.fct.2022.113185_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.livres.2019.11.004","article-title":"Pyrrolizidine alkaloids: an update on their metabolism and hepatotoxicity mechanism","volume":"3","author":"Xu","year":"2019","journal-title":"Liver Res."},{"issue":"12","key":"10.1016\/j.fct.2022.113185_bib43","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1007\/s00204-017-2013-y","article-title":"First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans","volume":"91","author":"Yang","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2022.113185_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.redox.2017.02.020","article-title":"Inhibition of Drp1 protects against senecionine-induced mitochondria mediated apoptosis in primary hepatocytes and in mice","volume":"12","author":"Yang","year":"2017","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.fct.2022.113185_bib45","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00204-019-02499-2","article-title":"Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids","volume":"93","author":"Yang","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.fct.2022.113185_bib46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jgh.14612","article-title":"Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"34","author":"Zhuge","year":"2019","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691522003830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691522003830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:22:15Z","timestamp":1759530135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691522003830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":46,"alternative-id":["S0278691522003830"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2022.113185","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Firm evidence for the detoxification of senecionine-induced hepatotoxicity via N-glucuronidation in UGT1A4\u2013humanized transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2022.113185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113185"}}